[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CS244141B2 - Method of 2-substituted 4-phenylimidazole's new amidine derivatives production - Google Patents

Method of 2-substituted 4-phenylimidazole's new amidine derivatives production Download PDF

Info

Publication number
CS244141B2
CS244141B2 CS845542A CS554284A CS244141B2 CS 244141 B2 CS244141 B2 CS 244141B2 CS 845542 A CS845542 A CS 845542A CS 554284 A CS554284 A CS 554284A CS 244141 B2 CS244141 B2 CS 244141B2
Authority
CS
Czechoslovakia
Prior art keywords
group
compound
alkyl
substituted
alkyl group
Prior art date
Application number
CS845542A
Other languages
Czech (cs)
English (en)
Other versions
CS554284A2 (en
Inventor
Giuseppe Bietti
Enzo Cereda
Arturo Donetti
Antonie Giachetti
Ferdinando Pagani
Original Assignee
Angeli Inst Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeli Inst Spa filed Critical Angeli Inst Spa
Priority to CS852801A priority Critical patent/CS244150B2/cs
Publication of CS554284A2 publication Critical patent/CS554284A2/cs
Publication of CS244141B2 publication Critical patent/CS244141B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Treatment Of Sludge (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Processing Of Solid Wastes (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CS845542A 1983-07-18 1984-07-18 Method of 2-substituted 4-phenylimidazole's new amidine derivatives production CS244141B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS852801A CS244150B2 (cs) 1983-07-18 1984-07-18 Způsob výroby nových amidinových derivátů 2-substituovaného 4-fenylimidazolu

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8322110A IT1206498B (it) 1983-07-18 1983-07-18 Derivati amidinici del4-fenilmidazolo 2-sostituto processi per la loro preparazione e loro uso farmaceutico.

Publications (2)

Publication Number Publication Date
CS554284A2 CS554284A2 (en) 1985-08-15
CS244141B2 true CS244141B2 (en) 1986-07-17

Family

ID=11191639

Family Applications (1)

Application Number Title Priority Date Filing Date
CS845542A CS244141B2 (en) 1983-07-18 1984-07-18 Method of 2-substituted 4-phenylimidazole's new amidine derivatives production

Country Status (28)

Country Link
US (1) US4649150A (it)
EP (1) EP0131973B1 (it)
JP (1) JPS6038367A (it)
KR (1) KR910000661B1 (it)
AT (1) ATE45149T1 (it)
AU (1) AU565292B2 (it)
CA (1) CA1257274A (it)
CS (1) CS244141B2 (it)
DD (1) DD232696A5 (it)
DE (1) DE3479212D1 (it)
DK (1) DK350084A (it)
ES (2) ES8601910A1 (it)
FI (1) FI842432A (it)
GB (1) GB2149395B (it)
GR (1) GR79981B (it)
HK (1) HK74287A (it)
HU (1) HU193292B (it)
IL (1) IL72417A (it)
IT (1) IT1206498B (it)
NO (1) NO162857C (it)
NZ (1) NZ208920A (it)
PH (1) PH21566A (it)
PL (2) PL143303B1 (it)
PT (1) PT78935B (it)
SG (1) SG48687G (it)
SU (2) SU1322979A3 (it)
YU (2) YU43367B (it)
ZA (1) ZA845490B (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888348A (en) * 1986-09-04 1989-12-19 Ciba-Geigy Corporation Substituted thioureas, isothioureas and carbodiimides
US6121260A (en) 1997-07-03 2000-09-19 Neurogen Corporation Method of treating conditions susceptible to modulation of NPY receptors with diarylimidazole derivatives
US6887870B1 (en) 1999-10-12 2005-05-03 Bristol-Myers Squibb Company Heterocyclic sodium/proton exchange inhibitors and method
IL149872A0 (en) 1999-12-16 2002-11-10 Schering Corp Substituted imidazole neuropeptide y y5 receptor antagonists
FR2917087B1 (fr) 2007-06-05 2012-09-21 Galderma Res & Dev Nouveaux 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique.
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209431B (it) * 1980-11-28 1989-07-16 Angeli Inst Spa Imidazolilfenil amidine, processi per la loro preparazione e loro impiego farmaceutico, ed intermedi di preparazione.

Also Published As

Publication number Publication date
PL248779A1 (en) 1985-12-03
ES8505962A1 (es) 1985-06-16
DK350084D0 (da) 1984-07-17
CA1257274A (en) 1989-07-11
YU115484A (en) 1986-12-31
GB2149395B (en) 1986-11-26
DK350084A (da) 1985-01-19
IT1206498B (it) 1989-04-27
HK74287A (en) 1987-10-23
NO162857B (no) 1989-11-20
NZ208920A (en) 1987-03-31
FI842432A0 (fi) 1984-06-15
PL143303B1 (en) 1988-02-29
NO162857C (no) 1990-02-28
SG48687G (en) 1987-07-24
DD232696A5 (de) 1986-02-05
YU43367B (en) 1989-06-30
YU112686A (en) 1987-12-31
ES534376A0 (es) 1985-11-01
JPS6038367A (ja) 1985-02-27
NO842921L (no) 1985-01-21
US4649150A (en) 1987-03-10
SU1322979A3 (ru) 1987-07-07
FI842432A (fi) 1985-01-19
EP0131973A1 (en) 1985-01-23
EP0131973B1 (en) 1989-08-02
IL72417A0 (en) 1984-11-30
ATE45149T1 (de) 1989-08-15
YU43701B (en) 1989-10-31
CS554284A2 (en) 1985-08-15
SU1313345A3 (ru) 1987-05-23
IL72417A (en) 1988-03-31
AU565292B2 (en) 1987-09-10
HU193292B (en) 1987-09-28
PL143732B1 (en) 1988-03-31
KR850001173A (ko) 1985-03-16
HUT34959A (en) 1985-05-28
GB2149395A (en) 1985-06-12
PL254625A1 (en) 1986-05-06
ZA845490B (en) 1986-03-26
DE3479212D1 (en) 1989-09-07
IT8322110A0 (it) 1983-07-18
PT78935A (de) 1984-08-01
ES8601910A1 (es) 1985-11-01
PH21566A (en) 1987-12-11
KR910000661B1 (ko) 1991-01-31
GR79981B (it) 1984-10-31
PT78935B (de) 1986-10-23
AU3080084A (en) 1985-01-24
GB8418149D0 (en) 1984-08-22
ES534375A0 (es) 1985-06-16

Similar Documents

Publication Publication Date Title
DE69834842T2 (de) Hemmung von raf-kinase unter verwendung von aryl- und heteroarylsubstituierten heterocyclischen harnstoffen
Petersen et al. Synthesis and hypotensive activity of N-alkyl-N''-cyano-N'-pyridylguanidines
DE69021472T2 (de) Pyrazolderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellung.
KR101441146B1 (ko) Npy y5 수용체 길항 작용을 갖는 아민 유도체
SU1400508A3 (ru) Способ получени производных арилтиазолов
KR880001317B1 (ko) 이미다졸릴페닐 아미딘 유도체의 제조방법
KR20220024486A (ko) 통합 스트레스 반응 경로의 억제제
Polish et al. Synthesis and evaluation on anticonvulsant and antidepressant activities of naphthoquinone derivatives containing pyrazole and pyrimidine fragments
EP0600831A1 (de) Phthalazinonderivate
CS244141B2 (en) Method of 2-substituted 4-phenylimidazole's new amidine derivatives production
EP0600830A1 (de) Substituierte Derivate von Diaminophthalimid als Protein-Tyrosin-Kinase-Hemmer
FI73989C (fi) Foerfarande foer framstaellning av nya kardiotoniskt verkande /(pyridinyl)-2-pyrimidinyl/ureaderivat.
FI84720C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara pyrido/2,3-d/pyrimidin-2,4-dionderivat.
JPH02138263A (ja) イミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
JP2005507362A (ja) カリウムチャンネル開放剤
US4166184A (en) 2h-imidazole-2-thione derivatives
CN109715609B (zh) 环己基苯甲酰胺化合物
JP2002534496A (ja) ((アミノイミノメチル)アミノ)アルカンカルボキシアミドおよび治療におけるその適用
EP0302164A1 (de) Guanidincarbonsäureester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CA1181080A (en) Imidazolylphenyl amidines, processes for their preparation and their pharmaceutical use, and intermediates of preparation
KR920004935B1 (ko) N-디메톡시 페닐알킬-n'-이미다졸릴페닐 아미딘 유도체 및 그의 제조방법
SU1705292A1 (ru) N-(4-хлорфенил)-2-[(бензо-2,1,3-тиадиазол-4-сульфонил)амино]-5-хлорбензамид, обладающий антигельминтной активностью
CS198187B2 (en) Method of producing new derivatives diazine
IL37323A (en) Thiazolidine derivatives,process for their preparation and compositions containing the same
DD263761A5 (de) Verfahren zur herstellung von pyridin-derivaten